GUARDION HEALTH SCIENCES INC (GHSI) Fundamental Analysis & Valuation
NASDAQ:GHSI • US40145Q5009
Current stock price
3.25 USD
-0.01 (-0.31%)
At close:
3.23 USD
-0.02 (-0.62%)
After Hours:
This GHSI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GHSI Profitability Analysis
1.1 Basic Checks
- In the past year GHSI was profitable.
- In the past year GHSI has reported a negative cash flow from operations.
- GHSI had negative earnings in 4 of the past 5 years.
- GHSI had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of GHSI (41.65%) is better than 100.00% of its industry peers.
- GHSI's Return On Equity of 46.34% is amongst the best of the industry. GHSI outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| ROIC | N/A |
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With an excellent Profit Margin value of 99.10%, GHSI belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
- GHSI has a Gross Margin (44.84%) which is comparable to the rest of the industry.
- GHSI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 99.1% | ||
| GM | 44.84% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
2. GHSI Health Analysis
2.1 Basic Checks
- GHSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
- GHSI has more shares outstanding than it did 1 year ago.
- GHSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- GHSI has an Altman-Z score of -5.72. This is a bad value and indicates that GHSI is not financially healthy and even has some risk of bankruptcy.
- Looking at the Altman-Z score, with a value of -5.72, GHSI is doing worse than 94.44% of the companies in the same industry.
- GHSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.72 |
ROIC/WACCN/A
WACC8.73%
2.3 Liquidity
- GHSI has a Current Ratio of 16.67. This indicates that GHSI is financially healthy and has no problem in meeting its short term obligations.
- GHSI has a better Current ratio (16.67) than 100.00% of its industry peers.
- A Quick Ratio of 16.59 indicates that GHSI has no problem at all paying its short term obligations.
- GHSI has a better Quick ratio (16.59) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 16.67 | ||
| Quick Ratio | 16.59 |
3. GHSI Growth Analysis
3.1 Past
- GHSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 154.16%, which is quite impressive.
- GHSI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -43.45%.
- GHSI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 67.11% yearly.
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%963.44%
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Sales Q2Q%-97.39%
3.2 Future
- The Earnings Per Share is expected to decrease by -110.23% on average over the next years. This is quite bad
- The Revenue is expected to grow by 9.78% on average over the next years. This is quite good.
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. GHSI Valuation Analysis
4.1 Price/Earnings Ratio
- GHSI is valuated cheaply with a Price/Earnings ratio of 7.56.
- 91.67% of the companies in the same industry are more expensive than GHSI, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 25.54, GHSI is valued rather cheaply.
- GHSI is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.56 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A cheap valuation may be justified as GHSI's earnings are expected to decrease with -110.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-110.23%
EPS Next 3YN/A
5. GHSI Dividend Analysis
5.1 Amount
- GHSI has a Yearly Dividend Yield of 153.85%, which is a nice return.
- In the last 3 months the price of GHSI has falen by -67.14%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
- Compared to an average industry Dividend Yield of 1.74, GHSI pays a better dividend. On top of this GHSI pays more dividend than 100.00% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, GHSI pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 153.85% |
5.2 History
- GHSI does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y-110.23%
EPS Next 3YN/A
GHSI Fundamentals: All Metrics, Ratios and Statistics
3.25
-0.01 (-0.31%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-12 2024-08-12/amc
Earnings (Next)11-14 2024-11-14/amc
Inst Owners7%
Inst Owner ChangeN/A
Ins Owners206.25%
Ins Owner Change0%
Market Cap4.39M
Revenue(TTM)6.43M
Net Income(TTM)6.37M
Analysts82.86
Price Target40.8 (1155.38%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 153.85% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-51.78%
Min Revenue beat(2)-97.77%
Max Revenue beat(2)-5.79%
Revenue beat(4)1
Avg Revenue beat(4)-25.02%
Min Revenue beat(4)-97.77%
Max Revenue beat(4)6.34%
Revenue beat(8)2
Avg Revenue beat(8)-14.67%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.56 | ||
| Fwd PE | N/A | ||
| P/S | 0.68 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.32 | ||
| P/tB | 0.32 | ||
| EV/EBITDA | N/A |
EPS(TTM)0.43
EY13.23%
EPS(NY)-1.04
Fwd EYN/A
FCF(TTM)-2.9
FCFYN/A
OCF(TTM)-2.9
OCFYN/A
SpS4.76
BVpS10.19
TBVpS10.19
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 99.1% | ||
| GM | 44.84% | ||
| FCFM | N/A |
ROA(3y)-59.1%
ROA(5y)-69.74%
ROE(3y)-76.49%
ROE(5y)-84.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.13%
GM growth 5Y-5.18%
F-Score6
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 16.67 | ||
| Quick Ratio | 16.59 | ||
| Altman-Z | -5.72 |
F-Score6
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)9.76%
Cap/Depr(5y)24.37%
Cap/Sales(3y)0.36%
Cap/Sales(5y)4.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)154.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%963.44%
EPS Next Y-669.3%
EPS Next 2Y-110.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.45%
Revenue growth 3Y86.44%
Revenue growth 5Y67.11%
Sales Q2Q%-97.39%
Revenue Next Year9.56%
Revenue Next 2Y9.78%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.97%
OCF growth 3YN/A
OCF growth 5YN/A
GUARDION HEALTH SCIENCES INC / GHSI Fundamental Analysis FAQ
What is the fundamental rating for GHSI stock?
ChartMill assigns a fundamental rating of 5 / 10 to GHSI.
What is the valuation status of GUARDION HEALTH SCIENCES INC (GHSI) stock?
ChartMill assigns a valuation rating of 2 / 10 to GUARDION HEALTH SCIENCES INC (GHSI). This can be considered as Overvalued.
How profitable is GUARDION HEALTH SCIENCES INC (GHSI) stock?
GUARDION HEALTH SCIENCES INC (GHSI) has a profitability rating of 3 / 10.
What is the valuation of GUARDION HEALTH SCIENCES INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for GUARDION HEALTH SCIENCES INC (GHSI) is 7.56 and the Price/Book (PB) ratio is 0.32.
What is the earnings growth outlook for GUARDION HEALTH SCIENCES INC?
The Earnings per Share (EPS) of GUARDION HEALTH SCIENCES INC (GHSI) is expected to decline by -669.3% in the next year.